-
公开(公告)号:US20100093010A1
公开(公告)日:2010-04-15
申请号:US12606792
申请日:2009-10-27
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 本发明还提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,该方法包括测定抑制胆固醇合成的活性或量化在细胞中积累的脂筏中的胆固醇。 本发明还旨在提供一种筛选胆固醇合成抑制剂,蛋白er牛儿基胆碱化调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US20090220524A1
公开(公告)日:2009-09-03
申请号:US12298151
申请日:2007-04-23
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakuob , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakuob , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395 , C07K16/18 , G01N33/573
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer.The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US08637274B2
公开(公告)日:2014-01-28
申请号:US12606792
申请日:2009-10-27
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
IPC分类号: C12N15/09
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 还旨在提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,其包括测定抑制胆固醇合成的活性或定量细胞中脂质筏中累积的胆固醇。 还旨在提供一种筛选胆固醇合成抑制剂,蛋白质香叶基香叶基调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ-分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US20120128694A1
公开(公告)日:2012-05-24
申请号:US13276501
申请日:2011-10-19
申请人: TAKESHI IWATSUBO , TATSUHIKO KODAMA , TAKAO HAMAKUBO , TAISUKE TOMITA , IKUO HAYASHI , YASUOMI URANO , HIROKO IWANARI , MASAO OHKUCHI
发明人: TAKESHI IWATSUBO , TATSUHIKO KODAMA , TAKAO HAMAKUBO , TAISUKE TOMITA , IKUO HAYASHI , YASUOMI URANO , HIROKO IWANARI , MASAO OHKUCHI
IPC分类号: A61K39/395 , A61P25/28
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer.The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US08398981B2
公开(公告)日:2013-03-19
申请号:US13276501
申请日:2011-10-19
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer. The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US20110165179A1
公开(公告)日:2011-07-07
申请号:US12962019
申请日:2010-12-07
申请人: Takeshi IWATSUBO , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi IWATSUBO , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395 , A61P25/28 , A61P35/00 , A61P35/02
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer.The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US20070161700A1
公开(公告)日:2007-07-12
申请号:US10584415
申请日:2004-12-28
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
IPC分类号: A61K31/401 , A61K31/366 , A61K31/22
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 还旨在提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,其包括测定抑制胆固醇合成的活性或定量细胞中脂质筏中累积的胆固醇。 还旨在提供一种筛选胆固醇合成抑制剂,蛋白质香叶基香叶基调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ-分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US08394376B2
公开(公告)日:2013-03-12
申请号:US12962019
申请日:2010-12-07
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer. The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
-
-
-
-
-
-
-